JPMorgan Chase & Co’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.3K | Buy |
14,900
+6,100
| +69% | +$13.2K | ﹤0.01% | 5217 |
|
|
2025
Q1 | $13.2K | Buy |
8,800
+5,000
| +132% | +$7.5K | ﹤0.01% | 5382 |
|
|
2024
Q4 | $19.1K | Hold |
3,800
| – | – | ﹤0.01% | 5233 |
|
|
2024
Q3 | $30.6K | Buy |
+3,800
| New | +$30.6K | ﹤0.01% | 5118 |
|
|
2024
Q1 | – | Sell |
-152
| Closed | -$2.84K | – | 6352 |
|
|
2023
Q4 | $2.84K | Buy |
+152
| New | +$2.84K | ﹤0.01% | 5633 |
|
|
2021
Q3 | – | Sell |
-8,024
| Closed | -$687K | – | 5505 |
|
|
2021
Q2 | $687K | Buy |
+8,024
| New | +$687K | ﹤0.01% | 3832 |
|